Red X iconGreen tick iconYellow tick icon
A postgraduate research opportunity at the University of Otago.

Details

Close date
Tuesday, 31 December 2024
Academic background
Health Sciences
Host campus
Dunedin
Qualification
Master's, Honours
Department
Pathology (Dunedin)
Supervisor
Dr Kunyu Li, Dr Kevin Ly, Professor Antony Braithwaite, Professor Mike Eccles

Overview

Treatment resistance has been reported in all types of anti-cancer therapies and it is one of the major hurdles that limits the outcome of cancer treatment. Many mechanisms of treatment resistance have been identified. However, how exactly these arise remains unclear.

This project aims to understand how immune response might influence genomic alteration in cancer cells and the evolution of the TIME, contributing to the initiation of treatment resistance to immunotherapies, using an animal model of melanoma.

It is suitable for a postgraduate student with substantial knowledge of immunology and/or cancer biology. Students with relevant laboratory experience in primary T cell culturing, mouse handling, tumour monitoring, flow cytometry analysis, and RNA sequencing analysis is preferred.

Depending on the student’s performance and the availability of research funding, this project could be continued for a PhD degree.

Close date

This research opportunity closes on Tuesday 31 December 2024.

Contact

Kunyu Li
Tel +64 21 155 9148
Emailkunyu.li@otago.ac.nz

Useful information

Similar research opportunities

Back to top